Evidence map›Paper›PMID 40814229›Full record

ArticleBriefings in bioinformatics2025

DriverOmicsNet: an integrated graph convolutional network for multi-omics exploration of cancer driver genes.

Yang-Hong Dai, Chia-Jun Chang, Po-Chien Shen, Wun-Long Jheng, Ding-Jie Lee, Yu-Guang Chen

Erratum issuedAbstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Yang-Hong DaiDepartment of Radiation Oncology, Tri-Service General Hospital, National Defense Medical University, No. 325, Sec. 2, Chenggong Rd., Neihu District, Taipei City 114202, Taiwan, Republic of China.ORCID 0000-0001-8054-0944
Chia-Jun ChangDepartment of Biomedical Engineering, National Cheng Kung University, No. 1, University Rd., Tainan City 701, Taiwan, Republic of China.ORCID 0000-0003-0977-8743
Po-Chien ShenDepartment of Radiation Oncology, Tri-Service General Hospital, National Defense Medical University, No. 325, Sec. 2, Chenggong Rd., Neihu District, Taipei City 114202, Taiwan, Republic of China.ORCID 0000-0003-2496-996X
Wun-Long JhengCancer Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Sec. 3, Zhongyang Rd., Hualien City 970473, Taiwan, Republic of China.
Ding-Jie LeeDivision of Nephrology, Department of Internal Medicine, Tri-Service General Hospital Keelung Branch, National Defense Medical University, No. 325, Sec. 2, Chenggong Rd., Neihu District, Taipei City 114202, Taiwan, Republic of China.ORCID 0000-0002-4480-9106
Yu-Guang ChenDivision of Hematology/Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, No. 325, Sec. 2, Chenggong Rd., Neihu District, Taipei City 114202, Taiwan, Republic of China.ORCID 0000-0003-4379-5416

Funding

National Defense Medical Centre MND-MAB-D-114084National Science and Technology Council Funding & Awards 114-2314-B-016-004-MY2Tri-Service General Hospital TSGH-E-113225/TSGH-E-114227VGH, TSGH, AS Joint Research Program 113DCA0200005
6 · The paper itself

Abstract

Cancer is a complex and heterogeneous group of diseases driven by genetic mutations and molecular changes. Identifying and characterizing cancer driver gene is crucial for understanding cancer biology and guiding precision oncology. Integrating multi-omics data can reveal the intricate molecular interactions underlying cancer progression and treatment responses. We developed a graph convolutional network (GCN) framework, DriverOmicsNet, that integrates multi-omics data using STRING protein-protein interaction networks and correlation-based weighted gene correlation network analysis (WGCNA). We applied this framework to 15 cancer types, analyzing 5555 tumor samples to predict cancer-related features such as homologous recombination deficiency, cancer stemness, immune clusters, tumor stage, and survival outcomes. DriverOmicsNet demonstrated superior predictive accuracy and model performance metrics across all target labels when compared with GCN models based on STRING network alone. Gene expression emerged as the most significant feature, reflecting the dynamic and functional state of cancer cells. The combined use of STRING PPI and WGCNA networks enhanced the identification of key driver genes and their interactions. Our study highlights the effectiveness of using GCNs to integrate multi-omics data for precision oncology. The integration of STRING PPI and WGCNA networks provides a comprehensive framework that improves predictive power and facilitates the understanding of cancer biology, paving the way for more tailored treatments.

Indexed as

Computational BiologyGene Regulatory NetworksGenomicsNeoplasmsGene Expression Regulation, NeoplasticHumansMultiomicsProtein Interaction Mapscancer driver genesgraph convolutional networksmulti-omicsprecision oncologySTRING PPIWGCNA

Identifiers

PMID40814229
PMCPMC12354958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.